Nestlé Buys Aimmune for $2.6B to Combat Food Allergies
In an effort to expand its health sciences business, Nestlé SA agreed to buy the rest of the partially owned biopharmaceutical company Aimmune Therapeutics Inc. for $2.6 billion, reported The Wall Street Journal (Aug. 31). …